Market Closed -
Canadian Securities Exchange
03:44:08 2023-08-28 pm EDT
|
5-day change
|
1st Jan Change
|
0.01
CAD
|
+100.00%
|
|
-.--%
|
-.--%
|
Fiscal Period: Octubre |
2021
|
2022
|
---|
Capitalization
1 |
5.183
|
0.1586
|
Enterprise Value (EV)
1 |
5.358
|
0.8979
|
P/E ratio
|
-0.72
x
|
-0.01
x
|
Yield
|
-
|
-
|
Capitalization / Revenue
|
43,146,441
x
|
472,339
x
|
EV / Revenue
|
44,602,593
x
|
2,673,899
x
|
EV / EBITDA
|
-1.09
x
|
-0.18
x
|
EV / FCF
|
-2,352,016
x
|
789,064
x
|
FCF Yield
|
-0%
|
0%
|
Price to Book
|
-14.4
x
|
-0.06
x
|
Nbr of stocks (in thousands)
|
3,570
|
17,283
|
Reference price
2 |
1.452
|
0.009178
|
Announcement Date
|
3/2/22
|
4/5/23
|
Fiscal Period: Octubre |
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
0.00622
|
0.1201
|
0.3358
|
EBITDA
1 |
-1.585
|
-1.062
|
-4.935
|
-4.953
|
EBIT
1 |
-1.63
|
-1.39
|
-4.989
|
-5.007
|
Operating Margin
|
-
|
-22,340.77%
|
-4,153.6%
|
-1,491.09%
|
Earnings before Tax (EBT)
1 |
-1.634
|
-1.386
|
-6.209
|
-5.812
|
Net income
1 |
-1.634
|
-1.386
|
-6.209
|
-5.812
|
Net margin
|
-
|
-22,277.56%
|
-5,168.9%
|
-1,730.85%
|
EPS
2 |
-3.675
|
-1.240
|
-2.005
|
-0.8720
|
Free Cash Flow
|
-
|
0.3098
|
-2.278
|
1.138
|
FCF margin
|
-
|
4,981.27%
|
-1,896.36%
|
338.87%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/21
|
3/4/21
|
3/2/22
|
4/5/23
|
Fiscal Period: October |
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
0.07
|
-
|
0.17
|
0.74
|
Net Cash position
1 |
-
|
0.02
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.0415
x
|
-
|
-0.0354
x
|
-0.1493
x
|
Free Cash Flow
|
-
|
0.31
|
-2.28
|
1.14
|
ROE (net income / shareholders' equity)
|
-
|
-433%
|
3,147%
|
205%
|
ROA (Net income/ Total Assets)
|
-
|
-164%
|
-672%
|
-924%
|
Assets
1 |
-
|
0.8441
|
0.9237
|
0.6289
|
Book Value Per Share
2 |
1.520
|
-0.0200
|
-0.1000
|
-0.1500
|
Cash Flow per Share
2 |
0
|
0.0700
|
0.0300
|
0
|
Capex
1 |
0.03
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/21
|
3/4/21
|
3/2/22
|
4/5/23
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 1.13M | | +25.83% | 661B | | +26.84% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +14.89% | 231B | | +5.17% | 200B | | -8.79% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|